Spatial Profiling of Circular RNAs in Cancer Reveals High Expression in Muscle and Stromal Cells

Juan L García-Rodríguez1, Ulrik Korsgaard2,3, Ulvi Ahmadov1

  • 1Department of Biomedicine, Aarhus University, Aarhus, Denmark.

Cancer Research
|July 21, 2023
PubMed

Insights

Circular RNAs (circRNAs) show altered expression in bulk tumor tissues due to cell type differences, not cancer itself. Spatial analysis is crucial for accurate circRNA research in cancer.

Area of Science:

  • Molecular Biology
  • Genomics
  • Cancer Research

Background:

  • Circular RNAs (circRNAs) are key molecules in cancer development.
  • Previous studies identified differentially expressed circRNAs using bulk tissue analysis.
  • Bulk tissue studies lack spatial expression pattern information.

Purpose of the Study:

  • Investigate spatial expression patterns of circRNAs in colon tumors.
  • Determine if differential circRNA expression in bulk tissues reflects true cancer-related changes.
  • Highlight limitations of bulk tissue analysis for circRNA research.

Main Methods:

  • RNA sequencing of bulk colon tumor and adjacent normal tissues.
  • Comparison of circRNA expression between cancer cells and normal epithelial cells.
  • Cell culture experiments manipulating proliferation rates.

Main Results:

  • Most circRNAs found differentially expressed in bulk colon tumor analysis were not significantly different between cancer and normal cells.
  • Differences were attributed to circRNA accumulation in quiescent muscle cells and dilution in proliferating cancer cells.
  • High circRNA content in muscle cells confounded bulk analyses in bladder and prostate cancers.

Conclusions:

  • Differential circRNA expression in bulk tissues often reflects cell type composition, not cancer-specific changes.
  • Spatial analysis is essential for accurate circRNA expression studies in cancer.
  • Bulk tissue analysis has significant limitations for understanding circRNA roles in cancer.

Related Concept Videos

Ribosome Profiling02:24

Ribosome Profiling

Ribosome profiling or ribo-sequencing is a deep sequencing technique that produces a snapshot of active translation in a cell. It selectively sequences the mRNAs protected by ribosomes to get an insight into a cell’s translation landscape at any given point in time.
Applications of ribosome profiling
Ribosome profiling has many applications, including in vivo monitoring of translation inside a particular organ or tissue type and quantifying new protein synthesis levels.
The technique...
3.6K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.1K
The Nucleolus02:55

The Nucleolus

The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
8.9K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.1K